Design and synthesis of fluorine-18 labeled matrix metalloproteinase inhibitors for cancer imaging
- 15 October 2002
- journal article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 45 (11), 975-986
- https://doi.org/10.1002/jlcr.616
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitorJournal of Molecular Biology, 2000
- Design and Therapeutic Application of Matrix Metalloproteinase InhibitorsChemical Reviews, 1999
- Homology Modeling of Gelatinase Catalytic Domains and Docking Simulations of Novel Sulfonamide InhibitorsJournal of Medicinal Chemistry, 1999
- Trendsin Molecular Medicine: Matrix metalloproteinases and their inhibitors in tumour growth and invasionAnnals of Medicine, 1999
- Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid DerivativesJournal of Medicinal Chemistry, 1998
- Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis LesionsJournal of Neuropathology and Experimental Neurology, 1996
- Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1995
- Structure of the Catalytic Domain of Fibroblast Collagenase Complexed with an InhibitorScience, 1994
- A simple and convenient method for esterification of tryptophan and other amino acidsThe Journal of Organic Chemistry, 1983
- A convenient synthesis of acetylenes: catalytic substitutions of acetylenic hydrogen with bromoalkenes, iodoarenes and bromopyridinesTetrahedron Letters, 1975